India pharma quality lapses force U.S. to look to China for vital drugs

Toxic medications, burned records, analog systems dim prospects for world's third largest pharmacy

SAYAN CHAKRABORTY and CISSY ZHOU

In the final weeks of 2022, a small team of inspectors from the U.S. Food and Drug Administration were far from home, investigating a pharmaceutical factory in western India.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.